Akums Drugs and Pharmaceuticals Ltd 2024 Annual Report with Sustainability Disclosures
Company: Akums Drugs and Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 180
The report presents consolidated FY2023-24 financial and workforce growth alongside a developing ESG program. It reports consolidated revenue from operations of Rs 41,781.82 million and a year-end workforce of 16,127 personnel. ESG highlights include a double materiality assessment, 32% renewable energy in the total energy mix, and zero workplace fatalities during the year. The group also reports a third-party assurance claim covering a majority of ESG data.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.